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Cardiovascular diseases are currently the leading 
cause of death for men and women both in developed 
and developing countries, and is caused by disorders 
of the heart and blood vessels, and includes coronary 
heart disease (heart attacks), cerebrovascular disease 
(stroke), hypertension, peripheral artery disease, 
rheumatic heart disease, congenital heart disease and 
heart failure.[1] Cardiotonic are drugs used to increase 
the  efficiency   and  improve  the  contraction  of  the  
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heart muscle, which leads to improved blood flow to 
all tissues of the body. Cardiotonic drugs increase the 
force of the contraction of the muscle (myocardium) 
of the heart. Most known cardiotonic agents belong 
to conventional medicine, while those in 
complementary systems of medicine remain 
inadequately studied.  The most common cardio 
tonics include cardiac glycosides (digoxin), 
catecholamine while others include ACE inhibitors, 
angiotensin receptor blockers, diuretics and digitalis 
which lack specificity in their action and produce 
adverse effects like dysrhythmias, hypotension, and 
bronchospasms.[2]  Thus the objective of the present 
study is to evaluate an Ayurvedic mineral based drug, 
Nagapashana, which has potent cardiotonicactivity 
and multiple actions that are beneficial in conditions  
associated with cardiac damage with no known 
adverse effects.  
In Ayurveda, cardiovascular diseases are the diseases 
of the Hrudaya which is considered to be heart in this 
context. It is one of the three Marmas, vital points. 
If Hrudaya doesn’t function properly, the other organs 
and tissues are also affected and damaged due to lack 
A B S T R A C T  
Nagapashana (Serpentine), a hydrous silicate of Magnesium (Mg6 (Sio10) OH8), is an important 
mineral drug used in Ayurveda, often in the form of Pishti (fine powder of Nagapashana). It is a 
Hrudya Dravya (cardiotonic). It is particularly indicated in Hrud Dourbalyaa, a condition associated 
with weakness of cardiac muscles. Cardiovascular disease is a leading cause of death in developed and 
developing countries. The present study was conducted to evaluate the cardio tonic activity of 
Nagapashana Pishti on Wistar rats. In the in-vivo study, Doxorubicin (2mg/kg) for 7 days was used to 
induce cardiac damage and the cardio tonic effect of Nagapashana Pishti at a dose of 150 and 300 
mg/kg.b.w, was compared with standard drug Digoxin. Biochemical assays like serum glutamic 
oxaloacetic transaminase (SGOT), Serum glutamic pyruvic transaminase (SGPT), lactate 
dehydrogenase (LDH), Total Cholesterol (TC), Triglyceride (TG) and Creatine kinase Monoenzyme B 
(CKMB) were done together with histopathology of heart tissue and ECG analysis. The in-vivo study 
revealed that Nagapashana Pishti (300mg/kg) was relatively more effective due to decreased QT and 
ST interval in ECG, significantly reduced levels of serum CKMB, SGOT, SGPT, TC and LDH and 
improvement in myocardial tissue. 
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of, or inadequate supply of nutrition and oxygen. The 
medicines or herbs that give strength to Hrudaya are 
called Hrudya Dravyas.[3] 
Ayurveda is based on a pharmacoepia that consists 
almost entirely of herbo-mineral drugs. Nagapashana 
was first mentioned in Ayurvedic texts under the 
heading ‘Sikatha Varga’ - a group of silicate 
compounds.[4],[5] It is famous as Jaharmohara in Hindi. 
Nagapashana is useful in Hrid-daurbalya (as a 
cardiotonic), Chardi (vomiting), Daha (burning 
sensation), Visuchika (colicky abdominal pain), Shwasa 
(respiratory disorders), Hrudroga (a wide spectrum of 
cardiovascular disorders), Kasa (cough) and 
Raktaarshas (bleeding heamarroids). In Ayurvedic 
thought, it is considered as Hrudya, helps to 
strengthen the brain and liver, improves bodily 
strength (Balya),  pacifies increased Pitta Dosha (one 
among the three main elements in Ayurveda), and is a 
potent aphrodisiac (Veerya Vardhaka).[6],[14]  
This study attempted to evaluate the cardiotonic 
activity of Nagapashana Pishti experimentally in 
Wistar albino rats.  
MATERIALS AND METHODS 
Collection of the drug 
The raw material Nagapashana was collected based 
on suitable Grahya Lakshana (and Mineralogical 
properties from Amruthkesari Depot, and preparation 
was done at Department of Rasashastra, RAMC, 
Bangalore. 
Preparation of the drug  
Shodhana of Nagapashana was done by Nirvapa 
(heating red hot and quenching in milk) method with 
Godugdha for 21 times and 14 days Bhavana 
(trituration) with Gulab Arka (rose distillate) till it 
attained the Pishti (fine powder).[6] 
Pharmacological Studies  
Nagapashana Pishti in gum acacia was subjected for 
the following pharmacological studies; 
1. Acute oral toxicity (OECD 423) 
2. In-vivo evaluation of cardiotonic activity of 
Nagapashana Pishti 
Animals 
The animal experiments were conducted at Invivo Bio 
sciences laboratory, Bangalore, India, and approved 
by the IAEC and care of laboratory animals were taken 
as per the guidelines of CPCSEA. 
Acute toxicity studies  
The acute toxicity study was performed in female 
Sprague Dawley rats by using fixed dose method as 
per OECD guideline 420. In this study, a sighting dose 
of 300 mg/kg was used, and no adverse signs were 
found. Subsequently additional doses of 1000 and 
2000 mg/kg were used. Total of 5 animals were used 
for each dose. Animals were observed for 24hrs and 
parameters like alertness, irritability, fearfulness, 
touch response, spontaneous activity, pain response, 
defecation, urination, etc. were recorded. Animals 
were observed till 14 days for any mortality. No 
clinical signs/adverse effects or death occurred in any 
of the doses tested. 
In-vivo evaluation of cardio tonic activity of 
Nagapashana Pishti 
Group Allocation 
SN Group Treatment Dose 
1. Control  Control - 
2. Positive   Doxorubicin 2mg/kg 
3. Standard  Doxorubicin + 
Digoxin 
2mg/kg + 100mcg/kg 




2mg/kg + 150mg/kg 







Doxorubicin 2 mg/kg, i.p administered for 7 days to 
induce cardiac toxicity in all groups except normal 
control. The other groups were receiving their 
respective treatment along with doxorubicin. Animals 
were divided into 5 groups, (n=6). Treated for 14 days. 
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1. Group I Normal control: Normal control received 
water 
2. Group II Disease control: Disease control treated 
with doxorubicin (2 mg/kg, i.p. for 7 days)  
3. Group III Standard: Standard control treated with 
digoxin (100 µg/kg, p.o., per day) along with 
doxorubicin (2 mg/kg, i.p. for 14days) 
4. Group IV Low Dose: Low dose of Nagapashana 
Pishti treated (150 mg/kg, p.o., per day) along 
with doxorubicin (2 mg/kg, i.p. for 14days)  
5. Group V High Dose: High dose of Nagapashana 
Pishti treated (300 mg/kg, p.o., per day) along 
with doxorubicin (2 mg/kg, i.p. for 14 days) 
Treatments were carried for 14 days.  
During treatment period several general observations 
were made which include mortality rate and body 
weight. At the end of treatment period, blood 
samples were collected under fasting conditions. 
Histopathology of heart was performed at the end 
treatment period to study cardiac damage occurred 
due to doxorubicin. 
Parameters measured 
After 24 hrs of last dose following parameters were 
measured: 
▪ ECG   
▪ Serum biomarkers like: CKMB, LDH, TC, TG, SGOT 
and SGPT.   
▪ Histopathology of transverse section of heart 
evaluation of cardiac enzymes 
Data Compilation and Statistical Analysis 
Averages of all the data were compiled and SEM were 
calculated. All the data were compiled using one-way 
ANOVA followed by Dennett’s multiple comparison 
tests.  
P values <0.05 were considered as statistically 
significant. 
RESULTS 
Acute oral toxicity Study (OECD 423) 
Nagapashana Pishti was subjected for acute oral 
toxicity study as per OECD 423 guidelines. It was 
administered up to a dose of 2000 mg/kg, p.o. (Limit 
test). The Pishti didn’t show any changes in 
behavioural parameter like alertness, fearfulness, 
irritability. No changes in neurological profile like 
spontaneous activity touch response, pain response 
and No changes in autonomic profile like urination, 
defecation. After 14 days of observation, No mortality 
was shown in Nagapashana Pishti treated animals. 
Hence, 150mg/kg and 300mg/Kg doses were selected 
for experimental study. 
Effect of Nagapashana Pishti on Cardiac Enzymes in 
Doxorubicin Induced Heart damage Model - An In-
vivo Study 
Administration of doxorubicin for 7 days (2mg/kg, i.p.) 
cause severe elevation of cardiac bio-markers due to 
cardiomyopathy. The level of Creatine kinase 
Monoenzyme B (CKMB) in normal group was found to 
be 45.91±0.927(IU/L). CKMB level was significantly 
raised in disease control 174.76±1.953 (IU/L). Digoxin 
treated group showed highly significant reduction in 
CKMB level, whereas Nagapashana Pishti 150 and 300 
mg/kg treated groups showed decreased CKMB level 
in dose dependent manner 61.53±1.779*** (IU/L), 
167.89±2.555* (IU/L) & 121.72±1.689*** (IU/L) 
respectively. The level of Serum Glutamic Oxaloacetic 
Transaminase (SGOT) in normal group was found to 
be 43.59±1.540 (IU/L). SGOT level was significantly 
raised in disease control 189.31±2.187 (IU/L). Digoxin 
treated group showed highly significant reduction in 
SGOT level, whereas Nagapashana Pishti 150 and 300 
mg/kg treated groups showed decreased SGOT level 
in dose dependent manner 37.77±1.890*** (IU/L), 
172.57±4.896** (IU/L) &79.77±2.669*** (IU/L) 
respectively. The level of Serum glutamic pyruvic 
transaminase (SGPT) in normal group was found to be 
20.23±0.555(IU/L). SGPT level was significantly raised 
in disease control 46.15±0.239 (IU/L). Digoxin treated 
group showed highly significant reduction in SGPT 
level, whereas Nagapashana Pishti 150 and 300 
mg/kg treated groups showed decreased SGPT level in 
dose dependent manner 22.03±0.799*** (IU/L), 
42.08±0.433* (IU/L) &29.53±0.672*** (IU/L) 
respectively. The level of Lactate De-Hydrogenase 
(LDH) in normal group found to be 73.63±1.121(IU/L). 
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LDH level was significantly raised in disease control 
166.00±2.050(IU/L). Digoxin treated group showed 
highly significant reduction in LDH level, whereas 
Nagapashana 150 and 300 mg/kg treated groups 
showed decreased LDH level in dose dependent 
manner 82.4±1.754***(IU/L), 161.68±2.334** (IU/L) 
&129.14±1.271*** (IU/L) respectively. The level of 
Total Cholesterol (TC) in normal group found to be 
81.53±0.579 (IU/L). TC level was significantly raised in 
disease control 161.95±3.716 (IU/L). Digoxin treated 
group showed highly significant reduction in TC level, 
where as Nagapashana 150 and 300 mg/kg treated 
groups showed decreased TC level in dose dependent 
manner 90.07±0.822***(IU/L),148.30±3.402** (IU/L) 
& 82.23±0.829*** (IU/L) respectively. The level of 
Triglyceride in normal group found to be 93.42±0.605 
(IU/L). TG level was significantly raised in disease 
control 280.43±2.677 (IU/L). Digoxin treated group 
showed highly significant reduction in TG level, 
whereas Nagapashana 150 and 300 mg/kg treated 
groups showed decreased TG level in dose dependent 
manner 102.93±1.786***(IU/L),176.75±1.848** (IU/L) 
& 82.12±1.235*** (IU/L) respectively. The above 
findings were suggested that there was significant 
increase in cardiac marker level in disease control 
group while in digoxin and Nagapashana treated 
groups shown reduction in cardiac marker levels 
significantly, compared to disease control group.  
Table 1: Effect of Nagapashana Pishti on Cardiac Enzymes. 
SN Groups CKMB (U/L) LDH (IU/L) SGOT (IU/L) SGPT (IU/L) TC (mg/dl) TG (mg/dl) 
1. Normal 45.91±0.927 73.63±1.121 43.59±1.540 20.23±0.555 81.53±0.579 93.42±0.605 
2. Disease 174.76±1.953 166.00±2.050 189.31±2.187 46.15±0.239 161.95±3.716 280.43±2.677 










129.14±1.271*** 79.77±2.669*** 29.53±0.672*** 82.23±0.829*** 81.53±1.235*** 
 
Table 2: ECG Interpretation 
SN Groups Heart Rate RR Interval QRS Interval 
1. Normal 312.95±12.552 0.17915±0.0006 0.01918±0.002315 
2. Disease 401.13±37.46 0.7074±0.2368 0.02866±0.002951 
3. Digoxin 270.516±2.281*** 0.2174±0.00093*** 0.0155±0.000428** 
4. Nagapashana Pishti 
150mg/kg 
274.26±2.479** 0.2174±0.00093** 0.01483±0.000477*** 
5. Nagapashana Pishti 
300mg/kg 
301.683±10.309*** 0.1856±0.00084*** 0.01829±0.002558* 
 
Effects of Nagapashana Pishti on ECG in Doxorubicin 
Induced cardiac toxicity 
ECG was recorded in all the groups after 24hrs of the 
last dose. Disease control group showed prolonged RR 
&  QT  intervals,  with  abnormalities in P  wave,  QRS  
 
complex and T wave compared with normal ECG. 
Digoxin & Nagapashana treated groups showed 
improvement in some ECG parameters compared with 
disease control group. 
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ECG pattern in Control indicates normal ECG. (Results 
are shown in Figure: 1)  
ECG pattern in the Disease Control indicates cardiac 
toxicity showing various parameters like. (Results are 
shown in Figure: 2)  
▪ Enlarged QRS complex  
▪ Elevated ST segment  
▪ Prolonged RR interval  
▪ Prolonged QT interval  
ECG Pattern in the Standard Control showing (Results 
are shown in Figure: 3)  
▪ Well defined P wave, QRS complex &T wave.  
▪ ST segment, RR interval, QT interval are improved 
compare to disease control group.  
ECG pattern in Nagapashana Pishti 150mg/showing 
(Results are shown in Figure: 4) 
▪ Decreased RR & QT interval  
▪ Slightly reduced in P wave  
▪ Showing improvement in elevated ST segment & 
enlarged QRS complex compare to disease control 
group. 
ECG pattern in Nagapashana 300 mg/kg showing 
(Results are shown in Figure: 5) 
▪ Showed significant improvement in all ECG 
parameters compare to disease control. 
▪ Decrease prolongation of QT and ST interval.  
ECG Images 
Figure 1: ECG of Normal control 
 
Figure 2: ECG of Disease control 
 
Figure 3: ECG of Standard treatment 
 
Figure 4: ECG of single dose of Nagapashana 
 
Figure 5: ECG of Double dose of Nagapashana 
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Effect of Nagapashana Pishti on Histopathology of 
Cardiac Tissues in Doxorubicin 
Induced Congestive Heart Failure Model - An Invivo 
Study Histopathological studies were carried out in 
normal, doxorubicin, standard and treated groups. 
Normal group: Showed clear integrity of myocardial 
membrane, without loss of myofibrils and cellular 
infiltration and with a clear intercalated disk, nuclei 
and myocytes. It also showed intact arrangement of 
the cardiac muscle fibres and muscle fibres showed 
intact integrity of myocardial cell membrane with 
striations. Results are shown in Figure: 6.  
 
Figure 6: Histopathology images 
Doxorubicin treated group: Resulted in cardiac muscle 
necrosis, cellular infiltration, vascular dilation, 
homogenous cytoplasm, fibrosis in focal areas. Results 
are shown in Figure: 7 Digoxin treated group: Showed 
normal architecture features of myocardium, without 
necrosis, cellular infiltration as well as vasculature was 
regenerated, decreased fibrosis in focal area and 
reduced vascular dilation compare to disease control 
group. All the Parameters like infiltration, fibrosis of 
focal areas, necrosis, etc were comparatively less in 
standard group. Results are shown in Figure: 6 
Nagapashana Pishti 150 mg/kg: Showed slightly 
improvement in arrangement of the cardiac muscle 
fibres with increase in integrity of myocardial cell 
membrane and myofibrils. Results are shown in 
Figure: 6 
Nagapashana Pishti 300 mg/kg: Showed significantly 
increase in arrangement of the cardiac muscle fibres 
with increase in integrity of myocardial cell membrane 
and myofibrils. Results are shown in Figure: 6.  
DISCUSSION 
Cardiovascular disease is one of the primary causes 
for hospitalization and death worldwide. In which 
heart is unable pump the sufficient blood properly 
and which results into reduced blood supply to vital 
organ.[7] Various cardio tonic drugs are useful in low 
output failure condition, which may occur due to 
myocardial ischemia, myocardial infarction, cardiac 
hypertrophy, cardiomyopathy, congenital heart 
defects, heart valve defects, etc. But these cardio 
tonic drugs have low therapeutic index with high side 
effects. Hence the research is focused on mineral 
based  drug. Along with herbs our ancient scholars 
were also well aware of the medicinal value of metals, 
minerals, aquatic products and gems etc. which are 
found in nature. Rasaouṣadhis have unique place in 
Ayurvedic therapeutics because of their qualities like 
Alpamātropayogitvāt (used in less dose), Arucher-
Aprasangata (no incidence of bad taste) and 
Kṣipramārogayadāyitvat (fast acting).[8]  
Thus the objective of present study is to evaluate the 
mineral based drug which having potent cardiotonic 
activity. Some of the Rasoushadhis like Prabakaravati, 
Yakutirasa, Hrudayaranava Rasa, Sangeyashma Pishti, 
Akikapisti is mentioned to treat Hrudroga in 
Ayurveda. 
Nagapashana is Serpentine, a hydrous silicate of 
Magnesium (Mg6 (Sio10) OH8).[9] It is mentioned 
under Sikathavarga - silicate compounds,[4],[5] It is 
famous as Jaharmohara in Hindi. It acts on Hrudaya 
Dourbalya,   It consists of  magnesium and silicate 
mainly, along with other.  Hence the present study 
was undertaken to evaluate cardiotonic activity of 
Nagapashana Pishti against doxorubicin induced 
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congestive cardiac failure in rats. Raw Nagapashana 
was collected, and  Pishti was prepared by classical 
method. Acute toxicity study was performed as per 
OECD 423 guidelines and Nagapashana Pishti  didn’t 
show any lethal effect up to a dose of 2000 mg/kg. 
Hence, (150 mg/kg) and (300 mg/kg) doses were 
selected for experimental study.  
In-vivo cardiotonic activity was evaluated in failed 
heart. Doxorubicin 2 mg/kg., i.p. for 7days leads to 
cardiomyopathy. Doxorubicin is a potent 
chemotherapeutic agent using for the treatment of 
cancers, which shows drastically decrease in weight, 
chronic cardiac side effects like congestive cardiac 
failure and cardiomyopathy. Clinical and laboratory 
findings of overall long term treatment with 
doxorubicin showed marked tachycardia, 
hypotension, cardiac dilation, ventricular failure due 
to elevation in serum enzymes such as CKMB, SGOT, 
SGPT, TC, TG and LDH levels. The level CKMB, SGOT, 
SGPT, TC, TG and LDH levels  significantly increased in 
disease control group compared to normal. The 
digoxin and Nagapashana treated groups showed 
decrease in CKMB, SGOT, SGPT, TC, TG and LDH levels, 
which are near to normal values. Nagapashana 300 
mg/kg showed more effective reduction in the above 
cardiac markers than Nagapashana 150 mg/kg. 
Doxorubicin which causes cardio toxicity results in 
changes in ECG pattern. ECG was recorded in all the 
groups after 24 hrs of the last dose. Disease control 
group showed prolonged RR & QT intervals, with 
abnormalities in P wave, QRS complex and T wave 
compared with normal ECG. Digoxin & Nagapashana  
treated groups showed improvement in all the ECG 
parameters compared with disease control group. 
Myocardial damage and toxicity of doxorubicin on 
architecture of heart was estimated by 
histopathological examination of heart tissue. 
Administration of doxorubicin leads to cardiac toxicity 
due to increased oxidative stress. An imbalance 
between endogenous myocardial oxidants and free 
radical production has been suggested to play major 
role in pathogenesis of CVD.[10] Myocardial damage 
and toxicity of doxorubicin on architecture of heart 
was estimated by histopathological examination of 
heart tissue. Normal group showed clear integrity of 
myocardial membrane, without cellular infiltration 
and loss of myofibrils and with a clear intercalated 
disk, nuclei and myocytes. Doxorubicin treated group 
showed cardiac muscle necrosis, cellular infiltration, 
homogenous cytoplasm, vascular dilation, fibrosis in 
focal areas. Animals treated with Nagapashana 
showed improvement in damage architecture of 
cardiac muscles. Digoxin treated group also showed 
improvement in the architecture of cardiac muscles. 
Nagapashana  300 mg/kg showed more effective 
improvement in architecture of the heart muscle than 
Nagapashana 150 mg/kg.C 
Exact correlation may not be possible between 
Ayurvedic  and modern description of heart diseases. 
But a reasonable comparison can be done on the basis 
of symptomatology.  
Hridrogavikruti - Vyanavayu controls all the activities 
of Hridaya including its rhythm. Disturbance of 
Vyanavayu gives rise to various Hridaya Vikrutis. 
Disturbance in contraction and expansion of muscles 
and palpitations, may be due to Vata and Pitta, and 
Mandata due to Kapha. It is very difficult to explain 
the exact mode of action of drug. But on the basis of 
certain principles and theories, an attempt has been 
made here to describe the probable mode of action of 
Nagapashana Pishti as cardio tonic. According to 
Ayurveda, the pharmacodynamics of a drug can be 
evaluated through its Panchabhoutika constitution 
and Rasapanchaka. Nagapashana has Gunas like 
Ruksha, Ushna, Hrudya, Medhya, Balya and Vishagna. 
It is Tridoshahara, mainly Pittanashaka and has 
Samasheethoshna Veerya. It strengthens the heart 
and brain, also improves Ojas and acts as Vishahara. 
By all these properties and because of Balya and 
Hrudya action, Nagapashana acts as Hrudya, gives 
strength to cardiac muscles and helps to improve the 
pumping capacity of heart, which can be correlated to 
cardio tonic. Since it is Ojovardaka also, it may help in 
preventing the occurrence of Cardiac diseases. Gulab 
is having the properties of Tikta, Katu, Kashaya, 
Madhura Rasa, Laghu, Snigdha Guna, Sheetha Veerya, 
Madhura Vipaka and Tridoshagna. It acts as brain 
tonic and is useful in heart diseases and bleeding 
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disorders. These Gunas also gets imbibed with 
Nagapashana and acts as Hrudya.[11] Godugdha is 
Madhura Rasa, Anabhishyandi, Snigdha, Guru, 
Sheetha Veerya, Madhura Vipaka, and Vata Pitta 
Nashaka. Cow’s milk is Rasayana, Balavardaka, 
Raktapittahara, Medhya and good for heart, increases 
life span and aphrodisiac. By these properties, it 
produces little moisture in Srotas, Doshas, Dhatus and 
Malas, which helps to improve the blood flow and 
muscle tonicity.[11] 
Magnesium is the main component of cardiac 
glycosides and ACE inhibitors, which are the best 
choice of treatment in cardiovascular diseases, as it 
coordinates the activity of the heart muscle and the 
nerves that initiate the normal heartbeat by 
improving the blood flow and decreases the heart’s 
work load.[12],[13] As Nagapashana is a hydrous 
magnesium silicate, which contains maximum 
percentage of magnesium, hence may be considered 
as cardio tonic, which can be correlated as Hrudya. 
CONCLUSION 
It is concluded that Nagapashana Pishti possesses 
cardiotonic activity. Nagapashana treated groups 
showed improvement in RR & QT interval with normal 
P wave, QRS complex & T wave in ECG and it also 
showed reduction in CKMB, SGOT, SGPT, TC, TG and 
LDH. Nagapashana treated groups showed 
improvement in architecture of cardiac muscle. 
Hence, it is concluded that Nagapashana Pishti 
hascardiotonic activity. Where Nagapashana 300 
mg/kg showed highly significant cardiotonic activity 
than Nagapashana 150 mg/kg. 
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